Schizoaffective disorder is a common, chronic, and frequently disabling psychiatric disorder. However, its pharmacologic treatment has not been well studied. The authors review studies of traditional and novel pharmacologic agents in treatment of schizoaffective disorder, and based on the findings, present preliminary pharmacologic treatment guidelines for the disorder.
Save
Cite
Advertisement
GAM ID: sidebar-top